NCT03526822View on ClinicalTrials.gov

Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Brain Tumor
Interventions
BIOLOGICAL

Blood sample

Five blood sample in pre-, post-operative period, before radiotherapy, before adjuvant temozolomide and at relapse in newly diagnosed glioblastoma

BIOLOGICAL

Tumor sample

One tumor sample in operative period

Trial Locations (1)

13354

RECRUITING

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER